2025-020 - BRET-based Method to Measure Protein-Ligand Interactions in Live Cells

Description:

Background

Target engagement quantification is crucial in drug discovery for understanding drug-protein interactions, mechanisms of action, and resistance. Traditional methods like activity-based protein profiling with gel fluorescence, while effective, are limited by low throughput, long processing times, and disruption of native protein functions. NanoBRET (bioluminescence resonance energy transfer) technologies have emerged for real-time, quantitative measurement of protein-ligand interactions in live cells but require optimization to maintain native protein characteristics and assay sensitivity.

 

 

 

 

 

 

 

 

 

Technology Description

USC researchers have developed a rapid, high-throughput NanoBRET-based platform for measuring protein-ligand interactions and target engagement in living cells. The platform combines proteins of interest fused to a minimal HiBiT peptide tag with fluorescent ligand tracers, enabling quantitative BRET-based measurements while minimizing potential disruption to native protein function. The modular approach can be adapted to different protein targets and compatible ligand systems. As proof of concept, the researchers demonstrated the platform using BTK (Bruton’s Tyrosine Kinase) and ibrutinib-derived covalent tracers, generating target engagement readouts within minutes with results comparable to traditional in-gel fluorescence. The platform was further validated through high-throughput screening of a kinase inhibitor library, successfully identifying potent BTK binders.

Key Advantages

  • Rapid and quantitative target engagement data obtainable within 20 minutes versus hours for traditional methods
  • High-throughput compatible, facilitating screening of extensive small molecule libraries efficiently
  • Minimal protein perturbation by using a small HiBiT tag, maintaining native protein-of-interest function and accurate interaction measurements
  • Versatile and modular, adaptable to various proteins of interest and covalent ligand systems

Stage of Development

  • Proof-of-concept with live-cell assays completed; validated through competitive binding and high-throughput inhibitor screens

Applications

  • Drug discovery and development, accelerating lead identification and optimization
  • Chemical biology research focused on protein-ligand interaction dynamics in live cellular environments
  • High-throughput screening platforms for small molecule libraries

Key Words

  • NanoBRET assay
  • Drug screening
  • Drug-target interactions

Patent Information:

  • Title: Covalent Probes Enable Measurement of Target Engagement
  • App Type: Utility
  • Country: United States
  • Serial No.: 19/750,478
  • Patent No.:  
  • File Date: 7/22/2026
  • Issued Date:  
  • Expire Date:  
  • Patent Status: Patent Pending